drugset / Trial / NCT01116401

Impact of Hot Flashes on Sleep and Mood Disturbance

NCT01116401

NaSingle-groupOpen-labelBasic science

Summary

We plan to enroll premenopausal women in a trial investigating the impact of hot flashes developed in response to an injection of a gonadotropin-releasing hormone agonist (GnRHa), leuprolide (brand name: Lupron), on sleep disruption and mood. This study is designed to mimic the menopause transition. We will collect data on sleep disruption and mood changes to assess their relationship to the development of hot flashes.

Timeline

Start
2009-11-03
Primary completion
2011-12-29
Completion
2012-01-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Leuprolide Other / unclassified 3.75 mg Intramuscular

Indications